Results

Total Results: 2,231 records

Showing results for "disease".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0599-131115.pdf
    June 20, 2013 - acknowledges uncertainty regarding the comparative effectiveness related to outcomes such as mortality and disease … Elderly, disabled or homebound adults living in the community who require primary care for a chronic disease … disability Intervention(s): Home-based primary care programs utilizing in-home visits for chronic disease … nursing home admissions, Health care utilization (e.g., ER visits, hospital admissions), cost, relevant disease-specific
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-liver-metastases-therapies_research-protocol.pdf
    September 27, 2012 - Hepatic metastasis from colorectal cancer is defined as resectable when it is anticipated that disease … The volume of disease in these patients is small, either in terms of lesion size or number of lesions … Patients whose treatment has failed or whose disease progressed while receiving systemic chemotherapy … These patients generally have large–volume, diffuse disease and are not candidates for ablation but … Intermediate outcomes that impact overall survival include time to progression of disease and tumor
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-applicability_methods.pdf
    July 01, 2012 - Spectrum of disease in practice and in studies. Source of population not described. … Exclude if no disease outcomes and outcomes key to understanding intended use case. … Spectrum Effect The severity or type of disease may effect the accuracy of the test. … or fetal anatomic survey, and MRI for detection of spinal conditions or joint disease. … Prevalence is inexorably tied to disease definitions that may also change over time.
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer-therapy_executive.pdf
    May 01, 2013 - to differentiate between patients with BCLC stage A and B liver disease across publications. … This was calculated from the date of disease response to treatment to the date of disease progression … Subgroups of interest include age, sex, HCC stage, disease etiology, lesion size, and multifocal disease … • No studies presented subgroup analyses on age, sex, disease etiology, or HCC stage. … RFA to PEI/PAI: disease etiology Insufficient None of the 3 RCTs reported subgroup analysis by disease
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - Ischemic heart disease CVD surgery and procedures Arrhythmias Quality of life Other heart disease … o Congestive heart failure o Valvular disease • Cerebrovascular disease o All stroke o Hemorrhagic … Use of complementary therapies in patients with cardiovascular disease. … Use of herbal products and potential interactions in patients with cardiovascular diseases. … Herbal medicine for the treatment of cardiovascular disease: clinical considerations.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease … Of Internal Medicine BMJ JAMA Lancet New England Journal Of Medicine Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_surveillance.pdf
    March 14, 2013 - CER # 28: Disease-Modifying Antirheumatic Drugs (DMARDs) in Children with Juvenile Idiopathic Arthritis … Lancet, and the New England Journal of Medicine) and five specialty journals (Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease … Of Internal Medicine BMJ JAMA Lancet New England Journal Of Medicine Annals of the Rheumatic Diseases … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease
  8. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - in this field focuses on drugs and biologics for irritable bowel syndrome and inflammatory bowel diseases … Bethesda (MD): National Digestive Diseases Information Clearinghouse (NDDIC); 2007 May [updated … National Digestive Diseases Information Clearinghouse (NDDIC). Short bowel syndrome. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National … Teduglutide, a glucagon-like peptide- 2 analog for the treatment of gastrointestinal diseases, including
  9. S143 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - medical service from a provider with a diagnosis coded according to International Classification of Diseases … in the past year 0.96 0.54 �0.01 0.74 0.83 0.12 Mean no. cardiovascular disease-related diagnoses … 0.25 0.17 �0.01 0.21 0.23 0.21 Mean no. cardiovascular disease-related hospitalizations in the past … Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. … The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
  10. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Horizon Scanning System – Potential High-Impact Interventions Report Priority Area 13: Pulmonary Disease … Slowing disease progression could lead to improved quality of life and reduced costs. … None of these approaches halts disease progression. … exacerbations, which may slow disease progression. … Slowed disease progression could lead to improved patient quality of life and reduced costs.
  11. 04-E029-1 Summary (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
    December 01, 2011 - Incidence of metastatic disease d. Quality of life e. Costs 5. … No more than 20 percent of the study sample could exhibit more advanced disease. … We also extracted definitions of disease progression. … additional basic and clinical research is needed to more accurately classify or predict those men whose diseases … No trial provided results from comparisons of AS with RP or RT in men with localized diseases.
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
    June 01, 2012 - Spectrum effect The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
  13. effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
    June 01, 2012 - Spectrum effect The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
  14. effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
    January 01, 2012 - Horizon Scanning System – Potential High Impact Interventions Report Priority Area 13: Pulmonary Disease … ES-2 Pulmonary Disease, Including Asthma, Interventions ........................................... … Priority Area 13: Pulmonary Disease, Including Asthma Topic High Impact Potential 1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease No high-impact potential … The primary treatment goal is to lessen symptoms and slow disease progression.
  15. S123 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
    October 01, 2007 - In addition, patients with more severe disease are assumed to have lower survival odds regardless of … severity, this leads to the following surgery choice model as a function of disease severity: S � c0 … If the survival risk of BCSI is thought to increase with L (b1 � 0), the patients with higher disease … and disease severity in- creases (eg, larger vs. smaller tumor size) as we move to the right on the … In this case, ESBC patients with the lowest disease severity and those with the highest disease severity
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology, Annals of Rheumatic Diseases … oral   DMARD:  Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
    March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology, Annals of Rheumatic Diseases … oral   DMARD:  Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE BMJ JAMA LANCET NEW ENGLAND JOURNAL OF MEDICINE ANNALS OF THE RHEUMATIC DISEASES
  18. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - Peripheral vascular disease. … morbidity, microvascular disease, and peripheral vascular disease. … lactic acidosis would help determine the safety of using this medication in populations with comorbid diseases … , congestive heart failure, liver disease, or psychiatric disease. … medications in effects on peripheral vascular disease. 2e.
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
    January 01, 2013 - Disease-Specific Health Outcomes The effect of CM on disease-specific outcomes was inconsistent. … Older adults with one or more chronic diseases Mortality. … Older adults with one or more chronic diseases Disease burden. … Older adults with one or more chronic diseases Personal contact. … A taxonomy for disease management: a scientific statement from the American Heart Association Disease
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
    July 01, 2012 - screening for reportable diseases such as syphilis or HIV. … Numerous clinical management effects might follow testing for coronary artery disease with CT. … An individual diagnosed with coronary disease might alter his or her lifestyle to reduce disease progression … Although the prognoses for some diseases are minimally modifiable with current treatments, most prognostic … Principles and practice of mass screening for disease. WHO Chronicle 1968;22:473. 8.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: